Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

8.84
-0.2600-2.86%
Post-market: 8.82-0.0200-0.23%17:02 EDT
Volume:1.99M
Turnover:17.73M
Market Cap:1.39B
PE:-2.80
High:9.24
Open:9.12
Low:8.80
Close:9.10
52wk High:10.94
52wk Low:4.16
Shares:157.00M
Float Shares:107.00M
Volume Ratio:0.75
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1619
EPS(LYR):-3.1619
ROE:-45.73%
ROA:-24.36%
PB:1.81
PE(LYR):-2.80

Loading ...

Vir Biotechnology Inc - Appoints Marianne De Backer as President in Addition to CEO on March 4, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 05

Vir Biotech Names CEO Marianne De Backer President

Reuters
·
Mar 05

Vir Biotechnology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 04

Vir Biotechnology price target raised to $20 from $15 at H.C. Wainwright

TIPRANKS
·
Mar 04

Vir Biotechnology Director Vicki L Sato Disposes of Common Shares

Reuters
·
Mar 04

Vir Biotechnology EVP and General Counsel Vanina de Verneuil Disposes of Common Shares

Reuters
·
Feb 27

Top Premarket Decliners

MT Newswires Live
·
Feb 26

BUZZ-Vir Biotech drops after $150 mln stock sale

Reuters
·
Feb 26

Stock Track | Vir Biotechnology Plunges 7.80% in Pre-market After Pricing Public Offering at $8.50 Per Share

Stock Track
·
Feb 26

Stock Track | Vir Biotechnology Plunges 5% After Pricing Public Offering at $8.50 Per Share

Stock Track
·
Feb 26

BRIEF-Vir Biotechnology Announces Pricing Of Public Offering Of Common Stock At $8.50 Per Share

Reuters
·
Feb 26

Vir Biotechnology Inc - Prices Public Offering at $8.50 per Share

THOMSON REUTERS
·
Feb 26

Vir Biotechnology Is Maintained at Overweight by Barclays

Dow Jones
·
Feb 26

Stock Track | Vir Biotechnology Soars 5.82% Intraday After Barclays Raises Price Target to $30

Stock Track
·
Feb 25

Stock Track | Vir Biotechnology Plunges 5.06% Post-Market Following $200 Million Stock Offering Announcement

Stock Track
·
Feb 25

Vir Biotechnology’s Call Highlights Astellas Deal, VIR-5500 Momentum

TIPRANKS
·
Feb 25

BUZZ-Vir Biotech slips after unveiling $200 mln stock offering plans

Reuters
·
Feb 25

Vir Biotechnology Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Feb 25

BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSet

Reuters
·
Feb 24

Vir Biotechnology Up Nearly 34%, on Pace for Largest Percent Increase Since January 2025 -- Data Talk

Dow Jones
·
Feb 24